94 related articles for article (PubMed ID: 8694503)
1. 31P MRS of human tumor cells: effects of culture media and conditions on phospholipid metabolite concentrations.
Franks SE; Kuesel AC; Lutz NW; Hull WE
Anticancer Res; 1996; 16(3B):1365-74. PubMed ID: 8694503
[TBL] [Abstract][Full Text] [Related]
2. Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy.
Muruganandham M; Alfieri AA; Matei C; Chen Y; Sukenick G; Schemainda I; Hasmann M; Saltz LB; Koutcher JA
Clin Cancer Res; 2005 May; 11(9):3503-13. PubMed ID: 15867253
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models.
Al-Saffar NM; Troy H; Ramírez de Molina A; Jackson LE; Madhu B; Griffiths JR; Leach MO; Workman P; Lacal JC; Judson IR; Chung YL
Cancer Res; 2006 Jan; 66(1):427-34. PubMed ID: 16397258
[TBL] [Abstract][Full Text] [Related]
4. The influence of medium formulation on phosphomonoester and UDP-hexose levels in cultured human colon tumor cells as observed by 31P NMR spectroscopy.
Shedd SF; Lutz NW; Hull WE
NMR Biomed; 1993; 6(4):254-63. PubMed ID: 8217527
[TBL] [Abstract][Full Text] [Related]
5. Levels of phospholipid metabolites in breast cancer cells treated with antimitotic drugs: a 31P-magnetic resonance spectroscopy study.
Sterin M; Cohen JS; Mardor Y; Berman E; Ringel I
Cancer Res; 2001 Oct; 61(20):7536-43. PubMed ID: 11606391
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the cytidine phospholipid pathways in human cancer cells and effects of 1-beta-D-arabinofuranosylcytosine: a noninvasive 31P nuclear magnetic resonance study.
Daly PF; Zugmaier G; Sandler D; Carpen M; Myers CE; Cohen JS
Cancer Res; 1990 Feb; 50(3):552-7. PubMed ID: 2153442
[TBL] [Abstract][Full Text] [Related]
7. Relationship between 31P metabolites and oncolytic viral therapy sensitivity in human colorectal cancer xenografts.
Silberhumer GR; Zakian K; Malhotra S; Brader P; Gönen M; Koutcher J; Fong Y
Br J Surg; 2009 Jul; 96(7):809-16. PubMed ID: 19526622
[TBL] [Abstract][Full Text] [Related]
8. Phospholipid metabolism in cancer cells monitored by 31P NMR spectroscopy.
Daly PF; Lyon RC; Faustino PJ; Cohen JS
J Biol Chem; 1987 Nov; 262(31):14875-8. PubMed ID: 3667610
[TBL] [Abstract][Full Text] [Related]
9. Variations in energy and phospholipid metabolism in normal and cancer human mammary epithelial cells.
Ting YL; Sherr D; Degani H
Anticancer Res; 1996; 16(3B):1381-8. PubMed ID: 8694505
[TBL] [Abstract][Full Text] [Related]
10. Changes in phosphate metabolism in thymoma cells suggest mechanisms for resistance to dexamethasone-induced apoptosis. A 31P NMR spectroscopic study of cell extracts.
Lutz NW; Tome ME; Aiken NR; Briehl MM
NMR Biomed; 2002 Aug; 15(5):356-66. PubMed ID: 12203227
[TBL] [Abstract][Full Text] [Related]
11. 31P NMR studies of cultured human tumor cells. Influence of pH on phospholipid metabolite levels and the detection of cytidine 5'-diphosphate choline.
Kuesel AC; Graschew G; Hull WE; Lorenz W; Thielmann HW
NMR Biomed; 1990 Apr; 3(2):78-89. PubMed ID: 2390457
[TBL] [Abstract][Full Text] [Related]
12. Melanoma tumors acquire a new phospholipid metabolism phenotype under cystemustine as revealed by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy of intact tumor samples.
Morvan D; Demidem A; Papon J; De Latour M; Madelmont JC
Cancer Res; 2002 Mar; 62(6):1890-7. PubMed ID: 11912170
[TBL] [Abstract][Full Text] [Related]
13. Role of nuclear magnetic resonance spectroscopy (MRS) in cancer diagnosis and treatment: 31P, 23Na, and 1H MRS studies of three models of pancreatic cancer.
Kaplan O; Kushnir T; Askenazy N; Knubovets T; Navon G
Cancer Res; 1997 Apr; 57(8):1452-9. PubMed ID: 9108445
[TBL] [Abstract][Full Text] [Related]
14. Phospholipid metabolites in 1H-decoupled 31P MRS in vivo in human cancer: implications for experimental models and clinical studies.
Negendank W; Li CW; Padavic-Shaller K; Murphy-Boesch J; Brown TR
Anticancer Res; 1996; 16(3B):1539-44. PubMed ID: 8694523
[TBL] [Abstract][Full Text] [Related]
15. Effects of abstinence from alcohol on the broad phospholipid signal in human brain: an in vivo 31P magnetic resonance spectroscopy study.
Estilaei MR; Matson GB; Payne GS; Leach MO; Fein G; Meyerhoff DJ
Alcohol Clin Exp Res; 2001 Aug; 25(8):1213-20. PubMed ID: 11505053
[TBL] [Abstract][Full Text] [Related]
16. Effects of the putative phospholipid precursors, inositol, choline, serine and ethanolamine, on formation and expansion of rabbit blastocysts in vitro.
Kane MT
J Reprod Fertil; 1989 Sep; 87(1):275-9. PubMed ID: 2516133
[TBL] [Abstract][Full Text] [Related]
17. Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis.
Katz-Brull R; Seger D; Rivenson-Segal D; Rushkin E; Degani H
Cancer Res; 2002 Apr; 62(7):1966-70. PubMed ID: 11929812
[TBL] [Abstract][Full Text] [Related]
18. Effects of chronic alcohol consumption on the broad phospholipid signal in human brain: an in vivo 31P MRS study.
Estilaei MR; Matson GB; Payne GS; Leach MO; Fein G; Meyerhoff DJ
Alcohol Clin Exp Res; 2001 Jan; 25(1):89-97. PubMed ID: 11198719
[TBL] [Abstract][Full Text] [Related]
19. Molecular causes of the aberrant choline phospholipid metabolism in breast cancer.
Glunde K; Jie C; Bhujwalla ZM
Cancer Res; 2004 Jun; 64(12):4270-6. PubMed ID: 15205341
[TBL] [Abstract][Full Text] [Related]
20. GALT deficiency causes UDP-hexose deficit in human galactosemic cells.
Lai K; Langley SD; Khwaja FW; Schmitt EW; Elsas LJ
Glycobiology; 2003 Apr; 13(4):285-94. PubMed ID: 12626383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
